BRISTOL-MYERS SQUIBB COMPANY Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31)
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) of $4.20 billion as of 2013-06-30, per its 10-Q filed 2013-07-25.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesFairValueDisclosure · last filed 2013-07-25
- 2013-06-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $4.20B.
- 2013-03-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $4.42B.
- 2012-12-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $4.70B.
- 2012-09-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $5.13B.
| Period end | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) as first filed |
|---|---|---|
| 2013-06-30 | $4.20B 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $4.42B 10-Q · filed 2013-04-25 | |
| 2012-12-31 | $4.70B 10-Q · filed 2013-07-25 | |
| 2012-09-30 | $5.13B 10-K · filed 2013-02-15 | |
| 2012-06-30 | $5.97B 10-K · filed 2013-02-15 | |
| 2012-03-31 | $6.31B 10-K · filed 2013-02-15 | |
| 2011-12-31 | $5.87B 10-K · filed 2013-02-15 | |
| 2011-09-30 | $6.54B 10-K · filed 2013-02-15 | |
| 2011-06-30 | $6.74B 10-K · filed 2013-02-15 | |
| 2011-03-31 | $6.45B 10-K · filed 2013-02-15 | |
| 2010-12-31 | $4.95B 10-K · filed 2012-02-17 | |
| 2010-09-30 | $3.34B 10-K · filed 2012-02-17 | $9.30B 10-Q · filed 2010-10-26 |
| 2010-06-30 | $4.33B 10-K · filed 2012-02-17 | |
| 2010-03-31 | $4.64B 10-K · filed 2012-02-17 | |
| 2009-12-31 | $8.07B 10-Q · filed 2010-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |